Cargando…
Author Correction: Calcium channel blocker amlodipine besylate therapy is associated with reduced case fatality rate of COVID-19 patients with hypertension
A Correction to this paper has been published: https://doi.org/10.1038/s41421-021-00267-0
| Autores principales: | , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Singapore
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8093281/ https://www.ncbi.nlm.nih.gov/pubmed/33941764 http://dx.doi.org/10.1038/s41421-021-00267-0 |
| _version_ | 1783687782954172416 |
|---|---|
| author | Zhang, Lei-Ke Sun, Yuan Zeng, Haolong Wang, Qingxing Jiang, Xiaming Shang, Wei-Juan Wu, Yan Li, Shufen Zhang, Yu-Lan Hao, Zhao-Nian Chen, Hongbo Jin, Runming Liu, Wei Li, Hao Peng, Ke Xiao, Gengfu |
| author_facet | Zhang, Lei-Ke Sun, Yuan Zeng, Haolong Wang, Qingxing Jiang, Xiaming Shang, Wei-Juan Wu, Yan Li, Shufen Zhang, Yu-Lan Hao, Zhao-Nian Chen, Hongbo Jin, Runming Liu, Wei Li, Hao Peng, Ke Xiao, Gengfu |
| author_sort | Zhang, Lei-Ke |
| collection | PubMed |
| description | A Correction to this paper has been published: https://doi.org/10.1038/s41421-021-00267-0 |
| format | Online Article Text |
| id | pubmed-8093281 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Springer Singapore |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-80932812021-05-05 Author Correction: Calcium channel blocker amlodipine besylate therapy is associated with reduced case fatality rate of COVID-19 patients with hypertension Zhang, Lei-Ke Sun, Yuan Zeng, Haolong Wang, Qingxing Jiang, Xiaming Shang, Wei-Juan Wu, Yan Li, Shufen Zhang, Yu-Lan Hao, Zhao-Nian Chen, Hongbo Jin, Runming Liu, Wei Li, Hao Peng, Ke Xiao, Gengfu Cell Discov Correction A Correction to this paper has been published: https://doi.org/10.1038/s41421-021-00267-0 Springer Singapore 2021-05-03 /pmc/articles/PMC8093281/ /pubmed/33941764 http://dx.doi.org/10.1038/s41421-021-00267-0 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
| spellingShingle | Correction Zhang, Lei-Ke Sun, Yuan Zeng, Haolong Wang, Qingxing Jiang, Xiaming Shang, Wei-Juan Wu, Yan Li, Shufen Zhang, Yu-Lan Hao, Zhao-Nian Chen, Hongbo Jin, Runming Liu, Wei Li, Hao Peng, Ke Xiao, Gengfu Author Correction: Calcium channel blocker amlodipine besylate therapy is associated with reduced case fatality rate of COVID-19 patients with hypertension |
| title | Author Correction: Calcium channel blocker amlodipine besylate therapy is associated with reduced case fatality rate of COVID-19 patients with hypertension |
| title_full | Author Correction: Calcium channel blocker amlodipine besylate therapy is associated with reduced case fatality rate of COVID-19 patients with hypertension |
| title_fullStr | Author Correction: Calcium channel blocker amlodipine besylate therapy is associated with reduced case fatality rate of COVID-19 patients with hypertension |
| title_full_unstemmed | Author Correction: Calcium channel blocker amlodipine besylate therapy is associated with reduced case fatality rate of COVID-19 patients with hypertension |
| title_short | Author Correction: Calcium channel blocker amlodipine besylate therapy is associated with reduced case fatality rate of COVID-19 patients with hypertension |
| title_sort | author correction: calcium channel blocker amlodipine besylate therapy is associated with reduced case fatality rate of covid-19 patients with hypertension |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8093281/ https://www.ncbi.nlm.nih.gov/pubmed/33941764 http://dx.doi.org/10.1038/s41421-021-00267-0 |
| work_keys_str_mv | AT zhangleike authorcorrectioncalciumchannelblockeramlodipinebesylatetherapyisassociatedwithreducedcasefatalityrateofcovid19patientswithhypertension AT sunyuan authorcorrectioncalciumchannelblockeramlodipinebesylatetherapyisassociatedwithreducedcasefatalityrateofcovid19patientswithhypertension AT zenghaolong authorcorrectioncalciumchannelblockeramlodipinebesylatetherapyisassociatedwithreducedcasefatalityrateofcovid19patientswithhypertension AT wangqingxing authorcorrectioncalciumchannelblockeramlodipinebesylatetherapyisassociatedwithreducedcasefatalityrateofcovid19patientswithhypertension AT jiangxiaming authorcorrectioncalciumchannelblockeramlodipinebesylatetherapyisassociatedwithreducedcasefatalityrateofcovid19patientswithhypertension AT shangweijuan authorcorrectioncalciumchannelblockeramlodipinebesylatetherapyisassociatedwithreducedcasefatalityrateofcovid19patientswithhypertension AT wuyan authorcorrectioncalciumchannelblockeramlodipinebesylatetherapyisassociatedwithreducedcasefatalityrateofcovid19patientswithhypertension AT lishufen authorcorrectioncalciumchannelblockeramlodipinebesylatetherapyisassociatedwithreducedcasefatalityrateofcovid19patientswithhypertension AT zhangyulan authorcorrectioncalciumchannelblockeramlodipinebesylatetherapyisassociatedwithreducedcasefatalityrateofcovid19patientswithhypertension AT haozhaonian authorcorrectioncalciumchannelblockeramlodipinebesylatetherapyisassociatedwithreducedcasefatalityrateofcovid19patientswithhypertension AT chenhongbo authorcorrectioncalciumchannelblockeramlodipinebesylatetherapyisassociatedwithreducedcasefatalityrateofcovid19patientswithhypertension AT jinrunming authorcorrectioncalciumchannelblockeramlodipinebesylatetherapyisassociatedwithreducedcasefatalityrateofcovid19patientswithhypertension AT liuwei authorcorrectioncalciumchannelblockeramlodipinebesylatetherapyisassociatedwithreducedcasefatalityrateofcovid19patientswithhypertension AT lihao authorcorrectioncalciumchannelblockeramlodipinebesylatetherapyisassociatedwithreducedcasefatalityrateofcovid19patientswithhypertension AT pengke authorcorrectioncalciumchannelblockeramlodipinebesylatetherapyisassociatedwithreducedcasefatalityrateofcovid19patientswithhypertension AT xiaogengfu authorcorrectioncalciumchannelblockeramlodipinebesylatetherapyisassociatedwithreducedcasefatalityrateofcovid19patientswithhypertension |